Yorktown Management & Research Company’s Regeneron Pharmaceuticals REGN Stock Holding History

Yorktown Management & Research Company’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-480	Closed	-$284K	–	219
2022 Q2	$284K	Hold	480	–	–	0.37%	124
2022 Q1	$335K	Hold	480	–	–	0.28%	141
2021 Q4	$303K	Hold	480	–	–	0.2%	183
2021 Q3	$290K	Hold	480	–	–	0.22%	181
2021 Q2	$268K	Buy	+480	New	+$243K	0.21%	200
2020 Q4	–	Sell	-500	Closed	-$280K	–	250
2020 Q3	$280K	Hold	500	–	–	0.26%	210
2020 Q2	$312K	Hold	500	–	–	0.28%	169
2020 Q1	$244K	Sell	500 -650	-57%	-$268K	0.25%	169
2019 Q4	$432K	Buy	+1,150	New	+$387K	0.23%	139
2019 Q2	–	Sell	-700	Closed	-$287K	–	349
2019 Q1	$287K	Hold	700	–	–	0.09%	261
2018 Q4	$261K	Hold	700	–	–	0.09%	265
2018 Q3	$283K	Hold	700	–	–	0.08%	306
2018 Q2	$241K	Hold	700	–	–	0.07%	323
2018 Q1	$241K	Hold	700	–	–	0.07%	337
2017 Q4	$263K	Hold	700	–	–	0.08%	327
2017 Q3	$313K	Hold	700	–	–	0.08%	230
2017 Q2	$344K	Hold	700	–	–	0.11%	103
2017 Q1	$271K	Hold	700	–	–	0.07%	214
2016 Q4	$257K	Hold	700	–	–	0.07%	229
2016 Q3	$281K	Hold	700	–	–	0.06%	184
2016 Q2	$244K	Hold	700	–	–	0.06%	232
2016 Q1	$252K	Hold	700	–	–	0.05%	274
2015 Q4	$380K	Hold	700	–	–	0.07%	184
2015 Q3	$326K	Hold	700	–	–	0.05%	221
2015 Q2	$357K	Hold	700	–	–	0.06%	175
2015 Q1	$316K	Hold	700	–	–	0.06%	192
2014 Q4	$287K	Buy	+700	New	+$275K	0.06%	184

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Yorktown Management & Research Company's REGN Position: Q3 2022 in Review

Yorktown Management & Research Company sold out of Regeneron Pharmaceuticals (REGN) in Q3 2022, closing a stake of 480 shares — an estimated $284K sold.

Yorktown Management & Research Company first reported a position in REGN in Q4 2014 and held it in 27 quarters. The position peaked at $432K in Q4 2019. 1,080 funds tracked by Wall St. Rank hold REGN as of Q3 2022.

Yorktown Management & Research Company reported no remaining Regeneron Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Yorktown Management & Research Company sold 480 Regeneron Pharmaceuticals shares in Q3 2022, an estimated $284K.
Yorktown Management & Research Company first reported a position in Regeneron Pharmaceuticals in Q4 2014 and held it in 27 quarters.
Yorktown Management & Research Company's Regeneron Pharmaceuticals position peaked at $432K in Q4 2019.
1,080 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2022.

Based on Yorktown Management & Research Company's 13F filing for Q3 2022, filed 4 Nov 2022.